Home
Bjarne Robberstad's picture

Bjarne Robberstad

Head of Department, Section for Ethics and Health Economics
  • E-mailbjarne.robberstad@uib.no
  • Phone+47 55 58 64 79+47 932 88 039
  • Visitor Address
    Alrek helseklynge, blokk D, Årstadveien 17
    5009 Bergen
  • Postal Address
    Postboks 7804
    5020 Bergen

Economic evaluation of health interventions in low income settings

Projects:

  1. INTH 306, Health Economics, Centre for International Health. Facilitator and main lecturer for the years 2002-2005.
  2. INTH 316, The Health Systems, Centre for International Health. Facilitator and main lecturer for the module ”Introduction to Economic Evaluation” for the years 2006-2010.
  3. The global HIV epidemic and research challenges to improve prevention, support and care. Lecturing and supervision at this TropEd course at the Centre for International Health for the years 2003-2010.
  4. ECON 221, Health Economics, Department of Economics, UiB. Guest lecturing 2006-2009.
  5. Miscellaneous guest lecturing at the University of Tromsø, the Univsersity College of Oslo and Norwegian Teacher Academy 2006 – 2010.
  6. Muhimbili University of Health and Allied Sciences: Teaching at Financing and Health Economics module in Master of Arts in Health Policy and Management, 2008.
Academic article
  • Show author(s) (2022). Visiting crowded places during the COVID-19 pandemic. A panel study among adult Norwegians. Frontiers in Public Health. 17 pages.
  • Show author(s) (2022). Public participation: healthcare rationing in the newspaper media. BMC Health Services Research.
  • Show author(s) (2022). Post-discharge morbidity and mortality in children admitted with severe anaemia and other health conditions in malaria-endemic settings in Africa: a systematic review and meta-analysis. The Lancet Child and Adolescent Health. 474-483.
  • Show author(s) (2022). Economic evaluation of postdischarge malaria chemoprevention in preschool children treated for severe anaemia in Malawi, Kenya, and Uganda: A cost-effectiveness analysis. EClinicalMedicine. 1-13.
  • Show author(s) (2022). Cost-Effectiveness of Mobile Stroke Unit Care in Norway. Stroke. 3173-3181.
  • Show author(s) (2022). Appraising Drugs Based on Cost-effectiveness and Severity of Disease in Norwegian Drug Coverage Decisions. JAMA Network Open. 9 pages.
  • Show author(s) (2021). Validity and responsiveness of EQ-5D-5L and SF-6D in patients with health complaints attributed to their amalgam fillings: a prospective cohort study of patients undergoing amalgam removal. Health and Quality of Life Outcomes. 1-12.
  • Show author(s) (2021). Protocol for a multicentre, parallel-group, open-label randomised controlled trial comparing ferric carboxymaltose with the standard of care in anaemic Malawian pregnant women: the REVAMP trial. BMJ Open. 10 pages.
  • Show author(s) (2021). Implementing standard antenatal care interventions: health system cost at primary health facilities in Tanzania. Cost Effectiveness and Resource Allocation. 8 pages.
  • Show author(s) (2021). Cost-effectiveness of household contact investigation for detection of tuberculosis in Pakistan. BMJ Open. 8 pages.
  • Show author(s) (2021). Adherence to community versus facility-based delivery of monthly malaria chemoprevention with dihydroartemisinin-piperaquine for the post-discharge management of severe anemia in Malawian children: A cluster randomized trial. PLOS ONE. 1-16.
  • Show author(s) (2020). The cost-effectiveness of using results-based financing to reduce maternal and perinatal mortality in Malawi. BMJ Global Health.
  • Show author(s) (2020). Should we discount future health benefits? Pro et contra (English translation) . Norsk Filosofisk tidsskrift. 1-28.
  • Show author(s) (2020). Should we discount future health benefits? Pro et contra. Norsk Filosofisk tidsskrift. 170-184.
  • Show author(s) (2020). Reporting of health equity considerations in cluster and individually randomized trials. Trials. 12 pages.
  • Show author(s) (2020). Poor self-reported adherence to COVID-19-related quarantine/isolation requests, Norway, April to July 2020. Eurosurveillance. 1-6.
  • Show author(s) (2020). Malaria Chemoprevention in the Postdischarge Management of Severe Anemia. New England Journal of Medicine. 2242-2254.
  • Show author(s) (2019). The cost-effectiveness of incentive-based active case finding for tuberculosis (TB) control in the private sector Karachi, Pakistan. BMC Health Services Research.
  • Show author(s) (2019). Taking an integrated knowledge translation approach in research to develop the CONSORT-Equity 2017 reporting guideline: an observational study. BMJ Open. 11 pages.
  • Show author(s) (2019). Malariaprofylakse til barn med alvorlig anemi redder liv – men hva er den beste leveringsmetoden på landsbygda i Malawi? Best Practice. 20-24.
  • Show author(s) (2019). Long-lasting insecticidal nets and indoor residual spraying may not be sufficient to eliminate malaria in a low malaria incidence area: Results from a cluster randomized controlled trial in Ethiopia. Malaria Journal. 1-15.
  • Show author(s) (2018). Who benefits from increased service utilisation? Examining the distributional effects of payment for performance in Tanzania. International Journal for Equity in Health. 1-16.
  • Show author(s) (2018). Post-discharge malaria chemoprevention (PMC) in Malawi: caregivers` acceptance and preferences with regard to delivery methods methods. BMC Health Services Research. 1-11.
  • Show author(s) (2018). Malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years in Uganda and Kenya: Study protocol for a multi-centre, two-arm, randomised, placebo-controlled, superiority trial. Trials.
  • Show author(s) (2018). Introducing post-discharge malaria chemoprevention (PMC) for management of severe anemia in Malawian children: a qualitative study of community health workers’ perceptions and motivation. BMC Health Services Research. 1-15.
  • Show author(s) (2018). Does payment for performance increase performance inequalities across health providers? A case study of Tanzania. Health Policy and Planning. 1026-1036.
  • Show author(s) (2018). Delivery strategies for malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years old in Malawi: a protocol for a cluster randomized trial. BMC Pediatrics. 1-8.
  • Show author(s) (2018). Cost-effectiveness of a combined intervention of long lasting insecticidal nets and indoor residual spraying compared with each intervention alone for malaria prevention in Ethiopia. Cost Effectiveness and Resource Allocation. 1-17.
  • Show author(s) (2017). When is a randomised controlled trial health equity relevant? Development and validation of a conceptual framework. BMJ Open. 9 pages.
  • Show author(s) (2017). Household costs and time to seek care for pregnancy related complications: The role of results-based financing. PLOS ONE. 18 pages.
  • Show author(s) (2017). Health Shocks and Household Welfare in Zambia: An Assessment of Changing Risk. Journal of International Development. 790-817.
  • Show author(s) (2017). Explaining changes in child health inequality in the run up to the 2015 millennium development goals (MDGs): The case of Zambia. PLOS ONE. 1-21.
  • Show author(s) (2017). Economic burden of malaria and predictors of cost variability to rural households in southcentral Ethiopia. PLOS ONE. 16 pages.
  • Show author(s) (2017). Early versus late BCG vaccination in HIV-1-exposed infants in Uganda: Study protocol for a randomized controlled trial. Trials. 1-17.
  • Show author(s) (2017). Does Free Public Health Care Increase Utilization and Reduce Spending? Heterogeneity and Long-Term Effects. World Development. 334-350.
  • Show author(s) (2017). Cost-effectiveness analysis of population-based tobacco control strategies in the prevention of cardiovascular diseases in Tanzania. PLOS ONE. 1-20.
  • Show author(s) (2017). Cost-benefit and extended cost-effectiveness analysis of a comprehensive adolescent pregnancy prevention program in Zambia: study protocol for a cluster randomized controlled trial. Trials. 1-10.
  • Show author(s) (2016). Malaria incidence and entomological findings in an area targeted for a cluster-randomized controlled trial to prevent malaria in Ethiopia: Results from a pilot study. Malaria Journal. 13 pages.
  • Show author(s) (2016). Equity in long-lasting insecticidal nets and indoor residual spraying for malaria prevention in a rural South Central Ethiopia. Malaria Journal. 11 pages.
  • Show author(s) (2016). Equity impact analysis of medical approaches to cardiovascular diseases prevention in Tanzania. Social Science and Medicine. 208-217.
  • Show author(s) (2016). Cost-effectiveness of medical primary prevention strategies to reduce absolute risk of cardiovascular disease in Tanzania: A Markov modelling study. BMC Health Services Research.
  • Show author(s) (2016). Combining long-lasting insecticidal nets and indoor residual spraying for malaria prevention in Ethiopia: Study protocol for a cluster randomized controlled trial. Trials.
  • Show author(s) (2016). Budget impact analysis of using dihydroartemisinin–piperaquine to treat uncomplicated malaria in children in Tanzania. PharmacoEconomics (Auckland). 303-314.
  • Show author(s) (2015). Factors associated with delivery outside a health facility: Cross-sectional study in rural Malawi. Tropical medicine & international health. 617-626.
  • Show author(s) (2015). Economic cost of primary prevention of cardiovascular diseases in Tanzania. Health Policy and Planning. 875-884.
  • Show author(s) (2015). Cost-effectiveness of peer counselling for the promotion of exclusive breastfeeding in Uganda. PLOS ONE. 18 pages.
  • Show author(s) (2015). Cost-effectiveness of live oral attenuated human rotavirus vaccine in Tanzania. Cost Effectiveness and Resource Allocation. 1-12.
  • Show author(s) (2014). The role of evidence in the decision-making process of selecting essential medicines in developing countries: the case of Tanzania. PLOS ONE. 10 pages.
  • Show author(s) (2014). Maternal and perinatal mortality by place of delivery in sub-Saharan Africa: A meta-analysis of population-based cohort studies. BMC Public Health.
  • Show author(s) (2014). Costs of promoting exclusive breastfeeding at community level in three sites in South Africa. PLOS ONE. 9 pages.
  • Show author(s) (2014). Cost-effectiveness of dihydroartemisinin-piperaquine compared with artemether-lumefantrine for treating uncomplicated malaria in children at a district hospital in Tanzania. Malaria Journal.
  • Show author(s) (2013). Role of pharmacoeconomics in developing countries. Farmeconomia. Health economics and therapeutic pathways. 3-5.
  • Show author(s) (2013). Infant feeding survival and Markov transition probabilities among children under age 6 months in Uganda. American Journal of Epidemiology. 453-462.
  • Show author(s) (2011). Incorporating concerns for equal lifetime health in evaluations of public health programs. Social Science and Medicine. 1711-1716.
  • Show author(s) (2011). Explaining household socio-economic related child health inequalities using multiple methods in three diverse settings in South Africa. International Journal for Equity in Health. 14 pages.
  • Show author(s) (2011). Economic evaluation of second generation pneumococcal vaccines in Norway. Vaccine. 8564-8574.
  • Show author(s) (2011). Cost of individual peer counselling for the promotion of exclusive breastfeeding in Uganda. Cost Effectiveness and Resource Allocation. 9 pages.
  • Show author(s) (2010). The health related quality of life of people living with HIV/AIDS in sub-Saharan Africa - a literature review and focus group study. Cost Effectiveness and Resource Allocation.
  • Show author(s) (2010). Preventing Mother to Child Transmission of HIV With Highly Active Antiretroviral Treatment in Tanzania-a Prospective Cost-Effectiveness Study. Journal of Acquired Immune Deficiency Syndromes. 397-403.
  • Show author(s) (2010). Further benefits by early start of HIV treatment in low income countries: survival estimates of early versus deferred antiretroviral therapy. AIDS research and therapy.
  • Show author(s) (2009). Estimating average inpatient and outpatient costs and childhood pneumonia and diarrhoea treatment costs in an urban health centre in Zambia. Cost Effectiveness and Resource Allocation.
  • Show author(s) (2009). Cost-effectiveness of anti-retroviral therapy at a district hospital in southern Ethiopia. Cost Effectiveness and Resource Allocation.
  • Show author(s) (2009). Cost estimates of HIV care and treatment with and without anti-retrovira thereapy at Arba Minch Hospital in southern Ethiopia. Cost Effectiveness and Resource Allocation.
  • Show author(s) (2007). Time preferences for health in northern Tanzania - An empirical analysis of alternative discounting models. PharmacoEconomics (Auckland). 73-88.
  • Show author(s) (2007). Cost-effectiveness of medical interventions to prevent cardiovascular disease in a sub-Saharan African country - the case of Tanzania. Cost Effectiveness and Resource Allocation.
  • Show author(s) (2005). QALYs vs DALYs vs LYs gained: What are the differences, and what difference do they make for health care priority setting. Norsk Epidemiologi. 183-191.
  • Show author(s) (2005). QALYs vs DALYs vs LYs gained. Norsk Epidemiologi. 183-191.
  • Show author(s) (2005). Estimation of private and social time preferences for health in northern Tanzania. Social Science and Medicine. 1597-1607.
  • Show author(s) (2005). Cost and cost-effectiveness of community based and health facility based directly observed treatment of tuberculosis in Dar es Salaam, Tanzania. Cost Effectiveness and Resource Allocation. 9 pages.
  • Show author(s) (2004). Cost-effectiveness of zinc as adjunct therapy for acute childhood diarrhoea in developing countries. Bulletin of the World Health Organization. 523-531.
  • Show author(s) (2003). The relationship between prevention of mother to child transmission of HIV and stakeholder decision making in Uganda: Implications for health policy. Health Policy. 199-211.
Academic lecture
  • Show author(s) (2021). Symposium 3: Monthly malaria chemoprevention for the post-discharge management (PMC) of severe anaemia in children - Clinical evidence, effective implementation, acceptability, epidemiological consequences, cost-effectiveness and equity impact (introduction and overview).
  • Show author(s) (2021). Epidemiological impact of PMC.
  • Show author(s) (2021). Effectiveness of community versus facility delivery of dihydroartemisinin-peraquine for post-discharge malaria chemoprevention in management of severe anaemia in Malawian children.
  • Show author(s) (2021). Cost-effectiveness of PMC.
  • Show author(s) (2021). Caregiver's acceptance and preferences with regard to delivery methods of PMC.
  • Show author(s) (2019). Efficacy and Effectiveness of Post-Discharge Malaria Chemoprophylaxis in Kenya, Uganda, and Malawi: Preliminary report .
  • Show author(s) (2018). Post-discharge risks of morbidity and mortality in children in malaria endemic settings in Africa: A systematic review and meta-analysis - Oral presentation.
  • Show author(s) (2017). Who benefits From Increased Service Utilization: Examining The Distributional Effects Of Payment For Performance in Tanzania.
  • Show author(s) (2017). Malaria Chemoprevention with monthly treatment with dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years in Uganda and Kenya: A 3-year, multi-centre, parallel-group, two-arm randomised placebo controlled superiority trial.
  • Show author(s) (2017). Delivery strategies of malaria chemoprevention for post-discharge management of children with severe anemia in Malawi (oral).
  • Show author(s) (2017). CPD Migori: Malaria Chemoprevention with monthly treatment with dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years in Uganda and Kenya: A 3-year, multi-centre, parallel-group, two-arm randomised placebo controlled superiority trial.
  • Show author(s) (2016). CPD meeting: Malaria Chemoprevention with monthly treatment with dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years in Uganda and Kenya: A 3-year, multi-centre, parallel-group, two-arm randomised placebo controlled superiority trial. .
  • Show author(s) (2015). Equity effects of the Pay-for-Performance scheme among health facilities in Tanzania.
  • Show author(s) (2008). Economic evaluation of health interventions - Tanzania perspectives.
  • Show author(s) (2008). Burden of disease among the poor in Tanzania. Rights, priorities and implementation.
  • Show author(s) (2007). ART in Africa does not lead to improved equity in health.
  • Show author(s) (2007). ART in Africa does not lead to improved equity in health.
  • Show author(s) (2005). Estimation of private and social time preferences for health in northern Tanzania.
  • Show author(s) (2005). Applied economic evaluations and studies on time preferences for health in Tanzania.
  • Show author(s) (2004). Førebygging av hjarte-karsjukdom i u-land - fornuftig bruk av knappe helsebudsjett i samfunn med høg forekomst av HIV-AIDS?
  • Show author(s) (2004). Cost-effectiveness in Priority Setting.
  • Show author(s) (2003). Cost-effectiveness of zinc as adjunct treatment in acute childhood diarrhea.
  • Show author(s) (2002). The relative cost-effectiveness of interventions to control HIV/AIDS in Tanzania.
  • Show author(s) (2002). The cost-effectiveness of selected interventions targeting major source of burden of disease in Tanzania.
  • Show author(s) (2002). Cost-effectiveness of interventions in management of acute childhood diarrhea.
  • Show author(s) (2002). Antiretroviral treatment in low income settings: priority setting considerations.
Academic literature review
  • Show author(s) (2020). Patient and health system costs of managing pregnancy and birth-related complications in sub-Saharan Africa: A systematic review. Health Economics Review. 1-15.
  • Show author(s) (2019). Prosigna Gene Signature to Assess Expected Benefit from Chemotherapy in Breast Cancer. Assessment of manufacturer’s submission. Folkehelseinstituttet.
  • Show author(s) (2012). Pharmacoeconomics and its implication on priority-setting for essential medicines in Tanzania: a systematic review. BMC Medical Informatics and Decision Making. 9 pages.

More information in national current research information system (CRIStin)

Enhanced contact investigation for tuberculosis is cost-effective in Pakistan

Adding enhanced contact investigation to the existing passive mode detected 3.8 times more cases of TB per index patient compared with passive contact investigation alone in Pakistan, and cost of US$238 per incremental patient with TB identified. This is the main conclusion of Hamidah Hussain and HELTER's new paper in BMJ Open.

 

Measuring health problems in patients with Medically Unexplained Physical Symptoms associated with amalgam fillings is challenging

Admassu Lamu and colleagues find that the GHC-index is a valid and responsive instrument for assessing symptom load in MUPS patients attributing their health complaints to amalgam fillings and undergoing amalgam removal.  Published recently in Acta Odontologica Scandinavica, with support from HELTER.

 

1. Malaria Chemoprevention for the post-discharge management of severe anaemia in children in Malawi, Uganda and Kenya (IPTpd): Moving towards policy. Budget 32.8 mill NOK, Research council of Norway, 2014-2019

PhD Social Economics

Title of dissertation: Economic evaluation of health interventions in sub-Saharan Africa. Applied economic evaluations and studies on time preferences for health in Tanzania. Dissertation for the PhD degree. University of Bergen 2005.

MSc Developing Economics

Title of thesis: Time Toil and Soil - Time preferences and soil conservation practices in northern Tanzania. Norwegian University of Life Sciences 1997.

Twitter